Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti

Acta Tropica

Volumn 162, Issue , 2016, Pages 27-34

  Weppelmann, Thomas A ^a   Fricken, Michael E von ^a   Lam, Brandon ^a   Telisma, Taina ^b   Existe, Alexandre ^c   Lemoine, Jean F ^c   Larkin, Joseph ^a   Okech, Bernard A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b Christianville Foundation   (Haïti)

^c Programme Nationale de Lutte Contre la Tuberculose   (Haïti)

Author keywords

Haiti; Malaria; Plasmodium vivax; Seroepidemiology

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; MEROZOITE SURFACE PROTEIN 1; PARASITE ANTIBODY; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; PARASITE ANTIGEN; PROTOZOON ANTIBODY;

EPIDEMIOLOGY; INFECTIOUS DISEASE; MALARIA; PARASITE TRANSMISSION; PROTOZOAN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY SCREENING; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAITI; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSTICS; PARASITE TRANSMISSION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; SEROCONVERSION; SEROEPIDEMIOLOGY; SEROLOGY; SEROPREVALENCE; YOUNG ADULT; BLOOD; CELL MEMBRANE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALARIA, VIVAX; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; TRANSMISSION; VERY ELDERLY;

HAITI;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL MEMBRANE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAITI; HUMANS; IMMUNOGLOBULIN G; MALARIA, VIVAX; MALE; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM VIVAX; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84976312647     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2016.05.011     Document Type: Article

References (21)

1. Agarwal, A., McMorrow, M., et al. The increase of imported malaria acquired in Haiti among US travelers in 2010. Am. J. Trop. Med. Hyg. 86:1 (2012), 9–10.
2. Arnold, B.F., Priest, J.W., et al. Serological measures of malaria transmission in Haiti: comparison of longitudinal and cross-Sectional methods. PLoS One, 9(4), 2014, e93684.
3. Bereczky, S., Martensson, A., et al. Short report: rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 72:3 (2005), 249–251.
4. Boncy, P.J., Adrien, P., Lemoine, J.F., Existe, A., Henry, P.J., Raccurt, C., et al. Malaria elimination in Haiti by the year 2020: an achievable goal?. Malaria J., 14, 2015, 237.
5. CDC (2013). Malaria Fact Sheet. Malaria. Atlanta, Centers for Disease Control and Prevention.
6. Fru-Cho, J., Bumah, V.V., et al. Molecular typing reveals substantial Plasmodium vivax infection in asymptomatic adults in a rural area of Cameroon. Malaria J., 13, 2014 170–170.
7. Genc, A., Eroglu, F., et al. Detection of Plasmodium vivax by nested PCR and real-Time PCR. The Korean Journal of Parasitology 48:2 (2010), 99–103.
8. Grann, V.R., Ziv, E., et al. Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br. J. Haematol. 143:2 (2008), 288–293.
9. Haro-González, J.L., Bernabeu-Wittel, M., et al. Malaria and travel to the Dominican Republic. Emerg. Infect. Dis. 11:3 (2005), 499–500.
10. Horuk, R., Chitnis, C.E., et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261:5125 (1993), 1182–1184.
11. Igonet, S., Vulliez-Le Normand, B., et al. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation?. J. Mol. Biol. 366:5 (2007), 1523–1537.
12. Jelinek, T., Grobusch, M., et al. Falciparum malaria in European tourists to the Dominican Republic. Emerg. Infect. Dis. 6:5 (2000), 537–538.
13. Lim, K.J., Park, J.W., Yeom, J.S., Lee, Y.H., Yoo, S.B., et al. ‘Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax’. Parasitol. Res. 92 (2004), 384–389.
14. Lindo, J.F., Bryce, J.H., et al. Plasmodium malariae in haitian refugees, Jamaica. Emerg. Infect. Dis. 13:6 (2007), 931–933.
15. Muhlberger, N., Jelinek, T., et al. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar. J., 3, 2004, 5.
16. PAHO, Regional Strategic Plan for Malaria in the Americas 2006–2010. 2006, Pan American Health Organization.
17. Patrick Kachur, S., Nicolas, E., Jean-François, V., Benitez, A., Bloland, P.B., Jean, Y.S., et al. Prevalence of malaria parasitemia and accuracy of microscopic diagnosis in Haiti: october 1995. Revista Panamericana de Salud Pública 3 (1998), 35–39.
18. WHO, World Malaria Report., 2015, World Health Organization, Geneva.
19. Weppelmann, T.A., Carter, T.E., et al. High frequency of the erythroid silent Duffy antigen genotype and lack of Plasmodium vivax infections in Haiti. Malar. J., 12, 2013, 30.
20. Wipasa, J., Suphavilai, C., Okell, L.C., Cook, J., Corran, P.H., Thaikla, K., et al. Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog., 6(2), 2010, e1000770.
21. von Fricken, M.E., Weppelmann, T.A., et al. Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti. Malar. J., 13, 2014, 361.